Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NEW JCM GROUP
300157
5
Shenzhen S-king Intelligent Equipment
688328
US Stock MarketDetailed Quotes
NNVC Nanoviricides
- 1.420
- +0.070+5.19%
Close Apr 25 16:00 ET
- 1.410
- -0.010-0.70%
Pre 08:04 ET
22.21MMarket Cap-2.00P/E (TTM)
1.420High1.371Low113.03KVolume1.380Open1.350Pre Close158.55KTurnover0.75%Turnover RatioLossP/E (Static)15.64MShares3.59052wk High2.14P/B21.40MFloat Cap0.94052wk Low--Dividend TTM15.07MShs Float262.500Historical High--Div YieldTTM3.63%Amplitude0.940Historical Low1.402Avg Price1Lot Size
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Nanoviricides Stock Forum
Breakthrough Drug Ready to Fight Measles Crisis: NanoViricides Offers Emergency Solution
NanoViricides' Game-Changing Antiviral Shows Superior Results Against Multiple Viruses
Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan
Tuesday, 4th March at 6:30 am
SHELTON, CT / ACCESS Newswire / March 4, 2025 / The HHS Department Secretary Robert F. Kennedy Jr. wrote an Opinion piece in the FoxNews entitled "Measles outbreak is call to action for all of us". He identifies an important issue that, "…there is no approved antiviral for those who may b...
Sadly, I'm gonna have to close this position.
Pre-revenue stage increases reliance on grants and other federal funding.
Tariff increases risk increasing COGS by 18-22%.
Capital structure will require dilutive funding in the future, with less than 6 months runway.
Penicillin of viruses. Starting phase 2. Long term hold.
Powerful New Weapon Against Bird Flu: NanoViricides' Drug Outperforms Tamiflu in Lab Tests
NanoViricides Engages CRO for Phase II Clinical Trial
Monday, 27th January at 6:30 am
SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE: NNVC) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum antiviral drug NV-387 further into the regulatory pipeline.
"NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in trea...
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
Wednesday, 8th January at 6:30 am
SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are going around already.
This season, two different genotypes of H5N1 bird flu, namely (a) the severe and lethal form D1.1 that has spread globally in b...
No comment yet